Brighton Jones LLC’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.35M Buy
+18,801
New +$1.45M 0.03% 375
2025
Q4
Sell
-19,542
Closed -$1.47M 247
2025
Q3
$1.47M Buy
19,542
+8,747
+81% +$599K 0.04% 288
2025
Q2
$745K Buy
10,795
+1,671
+18% +$110K 0.02% 400
2025
Q1
$618K Buy
9,124
+1,494
+20% +$89.4K 0.02% 341
2024
Q4
$342K Sell
7,630
-235
-3% -$13.2K 0.01% 479
2024
Q3
$495K Sell
7,865
-1,910
-20% -$111K 0.02% 320
2024
Q2
$577K Sell
9,775
-735
-7% -$46K 0.02% 324
2024
Q1
$838K Sell
10,510
-607
-5% -$46.4K 0.03% 253
2023
Q4
$878K Sell
11,117
-610
-5% -$43.4K 0.04% 229
2023
Q3
$819K Buy
11,727
+913
+8% +$64.7K 0.04% 210
2023
Q2
$748K Buy
10,814
+104
+1% +$7.4K 0.04% 230
2023
Q1
$796K Sell
10,710
-799
-7% -$67K 0.05% 208
2022
Q4
$1.07M Sell
11,509
-3,257
-22% -$314K 0.06% 162
2022
Q3
$1.41M Sell
14,766
-791
-5% -$78.3K 0.08% 127
2022
Q2
$1.44M Sell
15,557
-399
-3% -$38.9K 0.08% 128
2022
Q1
$1.61M Buy
15,956
+1,437
+10% +$151K 0.08% 127
2021
Q4
$1.5M Sell
14,519
-97
-0.7% -$8.96K 0.07% 132
2021
Q3
$1.24M Buy
14,616
+955
+7% +$80K 0.06% 131
2021
Q2
$1.14M Buy
13,661
+490
+4% +$40.1K 0.06% 141
2021
Q1
$991K Buy
13,171
+2,748
+26% +$200K 0.06% 150
2020
Q4
$712K Buy
10,423
+1,136
+12% +$73.9K 0.04% 171
2020
Q3
$542K Buy
9,287
+1,183
+15% +$73.6K 0.04% 184
2020
Q2
$527K Sell
8,104
-623
-7% -$39.2K 0.04% 171
2020
Q1
$518K Buy
8,727
+95
+1% +$6.34K 0.05% 157
2019
Q4
$641K Buy
8,632
+436
+5% +$30.6K 0.07% 157
2019
Q3
$517K Buy
8,196
+917
+13% +$54.3K 0.06% 164
2019
Q2
$397K Sell
7,279
-2,692
-27% -$145K 0.05% 191
2019
Q1
$538K Buy
9,971
+2,303
+30% +$142K 0.07% 160
2018
Q4
$502K Buy
7,668
+6
+0.1% +$448 0.07% 143
2018
Q3
$603K Sell
7,662
-4,420
-37% -$316K 0.07% 138
2018
Q2
$136K Buy
12,082
+37
+0.3% +$2.44K 0.02% 291
2018
Q1
$129K Sell
12,045
-616
-5% -$44.2K 0.02% 279
2017
Q4
$195K Buy
12,661
+3,215
+34% +$234K 0.02% 277
2017
Q3
$768K Buy
9,446
+91
+1% +$7.2K 0.1% 111
2017
Q2
$753K Sell
9,355
-236
-2% -$18.6K 0.11% 104
2017
Q1
$753K Buy
+9,591
New +$766K 0.18% 43
2016
Q4
Sell
-5,564
Closed -$495K 128
2016
Q3
$495K Sell
5,564
-137
-2% -$12.9K 0.08% 124
2016
Q2
$546K Sell
5,701
-999
-15% -$99.6K 0.1% 105
2016
Q1
$695K Sell
6,700
-345
-5% -$33.5K 0.13% 93
2015
Q4
$689K Sell
7,045
-219
-3% -$21.4K 0.13% 91
2015
Q3
$701K Buy
7,264
+159
+2% +$16.7K 0.15% 83
2015
Q2
$745K Buy
7,105
+88
+1% +$8.99K 0.17% 70
2015
Q1
$724K Buy
7,017
+157
+2% +$15.9K 0.16% 70
2014
Q4
$661K Sell
6,860
-4,175
-38% -$368K 0.15% 79
2014
Q3
$878K Buy
11,035
+3,075
+39% +$242K 0.2% 62
2014
Q2
$600K Sell
7,960
-441
-5% -$33.3K 0.14% 82
2014
Q1
$629K Buy
8,401
+2,560
+44% +$181K 0.15% 72
2013
Q4
$418K Buy
5,841
+1,437
+33% +$92.3K 0.1% 107
2013
Q3
$250K Buy
4,404
+501
+13% +$29.9K 0.07% 127
2013
Q2
$223K Buy
+3,903
New +$226K 0.07% 106

Other funds holding CVS

Brighton Jones LLC's CVS Position: Q1 2026 in Review

Brighton Jones LLC opened a new position in CVS Health (CVS) in Q1 2026: 18,801 shares worth $1.35M. The stake represents 0.03% of the portfolio and ranks #375 among its holdings. This is a return to the name: Brighton Jones LLC previously reported a position in CVS as recently as Q3 2025.

Brighton Jones LLC first reported a position in CVS in Q2 2013 and has held it in 50 quarters since. The position peaked at $1.61M in Q1 2022. 1,873 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Brighton Jones LLC held 18,801 shares of CVS Health worth $1.35M as of Q1 2026.
  • CVS Health was a new Brighton Jones LLC position in Q1 2026.
  • CVS Health made up 0.03% of Brighton Jones LLC's portfolio in Q1 2026, its #375 holding.
  • Brighton Jones LLC first reported a position in CVS Health in Q2 2013 and has held it in 50 quarters since.
  • Brighton Jones LLC's CVS Health position peaked at $1.61M in Q1 2022.
  • 1,873 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Brighton Jones LLC's 13F filing for Q1 2026, filed 28 Apr 2026.